Tissue-Specific Regulation of Aromatase Cytochrome P450 (CYP19) Expression

  • E. R. Simpson
  • M. S. Mahendroo
  • G. D. Means
  • M. W. Kilgore
  • C. J. Corbin
  • C. R. Mendelson
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 105)

Abstract

The conversion of androgens to estrogens is catalyzed by an enzyme complex known as aromatase, whose activity results in aromatization of the A ring of androgens, to form the phenolic A ring characteristic of estrogens with concomitant loss of the C19 angular methyl group. This enzyme complex is localized to the endoplasmic reticulum of cells in which it is expressed and consists of two components. The first is a form of cytochrome P450 known as aromatase cytochrome P450 (P450arom) (Mendelson et al. 1985; Chen et al. 1986; Kellis and Vickery 1987), the product of the CYP19 gene (Nebert et al. 1991). This heme protein is responsible for binding the C19 steroid substrate and catalyzing the concerted series of reactions leading to formation of the phenolic A ring. The second component is a flavoprotein, NADPH-cytochrome P450 reductase, which is a ubiquitous protein in the endoplasmic reticulum of most cell types and is responsible for transferring reducing equivalents from NADPH to any microsomal cytochrome P450 species with which it comes into contact. The aromatase reaction utilizes 3mol oxygen and 3mol NADPH for every mole of C19 steroid metabolized (Thompson and Siiteri 1974) (Fig. 1). There is general agreement that the first two oxygen molecules are utilized in the oxidation of the C19 angular methyl group. A growing consensus of opinion considers that the third oxygen attack is also on the C19 methyl group resulting in its loss as formic acid.

Keywords

Obesity Chrome Testosterone Glucocorticoid NADPH 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter H, Lenoir G, Leder P (1983) The human c-myc oncogene: structural consequences of translocation into the lgH locus in Burkitt lymphoma. Cell 34: 779–787PubMedCrossRefGoogle Scholar
  2. Chen S, Shively JE, Nakajin S, Shinoda M, Hall PF (1986) Amino terminal sequence analysis of human placenta aromatase. Biochem Biophys Res Commun 135: 713–719PubMedCrossRefGoogle Scholar
  3. Cole PA, Robinson CH (1988) A peroxide model reaction for placental aromatase. J Am Chem Soc 110: 1284CrossRefGoogle Scholar
  4. Corbin CJ, Graham-Lorence S, McPhaul M, Mason JI, Mendelson CR, Simpson ER (1988) Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sei USA 85: 8948–8953CrossRefGoogle Scholar
  5. de Pragter-Holthuizen P, Jansen M, van der Kämmen RA, van Schaik FMA, Sussenbach JS (1988) Differential expression of the human insulin-like growth factor II gene. Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochim Biophys Acta 950: 282–295Google Scholar
  6. Di Mattia GE, Gellerson B, Duckworth ML, Friesen GH (1990) Human prolactin gene expression: the use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 265: 16412–16421Google Scholar
  7. Edman CD, MacDonald PC (1978) Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 130: 456PubMedGoogle Scholar
  8. Edman CD, MacDonald PC, Combes B (1975) Extraglandular production of estrogens in subjects with liver disease. Gastroenterology 69:819 Fritz IB, Griswold MD, Louis BF, Dorrignton JH (1976) Similarity of responses of cultured Sertoli cells to cholera toxin and FSH. Mol Cell Endocrinol 5: 289Google Scholar
  9. Gonzalez-Crespo S, Boronat A (1991) Expression of the rat growth hormone- releasing hormone gene in placenta is directed by an alternative promoter. Proc Natl Acad Sei USA 88: 8749–8753CrossRefGoogle Scholar
  10. Gordon GG, Olivo J, Rafii F, Southern AL (1975) Conversion of androgens to estrogens in cirrhosis of the liver. J Clin Endocrinol Metab 40: 1018PubMedCrossRefGoogle Scholar
  11. Graham-Lorence S, Khalil M, Lorence MC, Mendelson CR, Simpson ER (1991) Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. J Biol Chem 266 /18: 11939–11946PubMedGoogle Scholar
  12. Grodin JM, Siiteri PK, MacDonald PC (1973) Source of estrogen production in the postmenopausal women. J Clin Endocrinol Metab 36: 207PubMedCrossRefGoogle Scholar
  13. Harada N (1988) Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem Biophys Res Commun 156: 725–732PubMedCrossRefGoogle Scholar
  14. Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y (1990) Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun 166: 365–372PubMedCrossRefGoogle Scholar
  15. Hemsell DL, Grodin J, Breuner PF, Siiteri PK, MacDonald PC (1974) Plasma precursors of estrogen II correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab 38: 476PubMedCrossRefGoogle Scholar
  16. Hickey GJ, Krasnow JS, Beattie WG, Richards JS (1990) Aromatase cytochrome P450 in rat ovarian granulosa cells before and after luteinization; adenosine 3′,5′-monophosphate — dependent and independent regulation, cloning and sequencing of rat aromatase cDNA and 5′-genomic DNA. Mol Endocrinol 4: 3–12PubMedCrossRefGoogle Scholar
  17. Izzo P, Constanzo P, Lupo A, Rippa E, Paolella G, Salvatore F (1988) Human aldolase A gene: structural organization and tissue-specific expression by multiple promoters and alternate mRNA processing. Eur J Biochem 174: 569–578PubMedCrossRefGoogle Scholar
  18. Kellis JT, Vickery LE (1987) Purification and characterization of human placental aromatase cytochrome P-450. J Biol Chem 262: 4413–4420PubMedGoogle Scholar
  19. Kilgore MW, Means GS, Mendelson CR, Simpson ER (1992) Alternative promotion of aromatase cytochrome P450 gene expression in human fetal tissues. Mol Cell Endocrinol 83: R9–R16PubMedCrossRefGoogle Scholar
  20. Magnuson MA, Shelton KD (1989) An alternate promoter in the glucokinase gene is active in the pancreatic ß cell. J Biol Chem 264: 15936–15942PubMedGoogle Scholar
  21. Mahendroo MS, Means GD, Mendelson CR, Simpson ER (1991) Tissue-specific expression of human P450arom: the promoter responsible for expression in adipose is different from that utilized in placenta. J Biol Chem 266: 11276–11281PubMedGoogle Scholar
  22. Matsumine H, Herbert MA, Ignatius Ou SH, Wilson JD, McPhaul MJ (1991) Aromatase mRNA in the extragonadal tissues of chickens with the henny- feathering trait is derived from a distinctive promoter structure that contains a segment of a retrovival long terminal repeat. J Biol Chem 266: 19900–19907PubMedGoogle Scholar
  23. McNatty KP, Baird DT, Bolton A, Chambers P, Corker CS, McLean H (1976) Concentrations of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. J Endocrinol 71: 77PubMedCrossRefGoogle Scholar
  24. McPhaul MJ, Noble JF, Simpson ER, Mendelson CR, Wilson JD (1988) The expression of a functional cDNA encoding the chicken cytochrome P450arom (aromatase) that catalyzes the formation of estrogen from androgen. J Biol Chem 263: 16358–16363PubMedGoogle Scholar
  25. Means GD, Mahendroo MS, Corbin CJ, Mathis MJ, Powell FE, Mendelson CR, Simpson ER (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264: 19385–19391PubMedGoogle Scholar
  26. Means GD, Kilgore MW, Mahendroo MS, Mendelson CR, Simpson ER (1991) Promoting estrogen biosynthesis: tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol 5: 2005–2013PubMedCrossRefGoogle Scholar
  27. Mendelson CR, Wright EE, Evans CT, Porter JC, Simpson ER (1985) Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 and their use in its purification. Arch Biochem Bipphys 243:480–491 Mendelson CR, Corbin CJ, Smith ME, Smith J, Simpson ER (1986) Growth factors suppress and phorbol esters potentiate the action of dibutyryl cyclic AMP to stimulate aromatase activity of human adipose stromal cells. Endocrinology 118: 968CrossRefGoogle Scholar
  28. Naftolin F, Ryan KJ, David IJ, Reddy VV, Flores F, Petro Z, Kuhn M (1975) The formation of estrogen by central neuroendocrine tissues. Recent Prog Horm Res 31: 295PubMedGoogle Scholar
  29. Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyersisen R, Fujii-Kuriyama Y, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Loper JC, Sato R, Waterman MR, Waxman DJ (1991) The P450 superfamily: update on new sequences, gene mapping and recommended nomenclature. DNA Cell Biol 10: 1–14PubMedCrossRefGoogle Scholar
  30. O’Neill JS, Elton RA, Miller WR (1988) Aromatase activity in adipose tissue from breast quadrants: a link with tumor site. Br Med J 296: 741CrossRefGoogle Scholar
  31. Roselli CE, Horton LE, Resko J A (1985) Distribution and regulation of aromatase activity in the rat hypothalamus and limbic systems. Endocrinology 117: 2471PubMedCrossRefGoogle Scholar
  32. Sengupta J, Roy SK, Manchada SK (1982) Effect of an oestrogen inhibitor, 1,4,6- androstatriene-3,17-dione, on mouse embryo developoment in vitro. J Reprod Fertil 66: 63PubMedCrossRefGoogle Scholar
  33. Simpson ER, Acherman GE, Smith ME, Mendelson CR (1981) Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticoids. Proc Natl Acad Sci USA 78: 5690PubMedCrossRefGoogle Scholar
  34. Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S, Hendelson CR (1989) Regulation of estrogen biosynthesis by human adipose cells. Endocr Rev 10: 136–148PubMedCrossRefGoogle Scholar
  35. Terashima M, Toda K, Kawamoto T, Kuribayashi, I, Ogawa Y, Maeda T, Shizuta Y (1991) Isolation of a full-lenth cDNA encoding mouse aromatase P450. Arch Biochem Biophys 285 /5: 231–237PubMedCrossRefGoogle Scholar
  36. Thompson EA Jr, Siiteri PK (1974) Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249: 5364PubMedGoogle Scholar
  37. Toda K, Terashima M, Mitsuuchi Y, Yamasaki Y, Yokoyama Y, Nojima S, Ushiro H, Maeda T, Yamamoto Y, Sagara Y, Shizuta Y (1989) Alternative usage of different poly (A) addition signals for two major species of mRNA encoding human aromatase P-450. FEBS Lett 247: 371–376PubMedCrossRefGoogle Scholar
  38. Toda K, Terashima M, Kawamoto T, Sumimoto H, Yokoyama Y, Kuribayashi I, Mitsuuchi Y, Maeda T, Yamamoto Y, Sagara Y, Ikeda H, Shizuta Y (1990) Structural and functional characterization of human aromatase P450 gene. Eur J Biochem 193: 559–565PubMedCrossRefGoogle Scholar
  39. Tsai-Morris CH, Aquilana DR, Dufau ML (1984) Gonadotropic regulation of aromatase activity in the adult rat testis. Ann NY Acad Sci 438: 666PubMedCrossRefGoogle Scholar
  40. Valladares LE, Payne AH (1979) Induction of testicular aromatization by luteinizing hormone in mature rats. Endocrinology 105: 431PubMedCrossRefGoogle Scholar
  41. Visvader J, Verma IM (1989) Differential transcription of Exon 1 of the human c-fms gene in placental trophoblasts and monocytes. Mol Cell Biol 9: 1336–1341PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • E. R. Simpson
  • M. S. Mahendroo
  • G. D. Means
  • M. W. Kilgore
  • C. J. Corbin
  • C. R. Mendelson

There are no affiliations available

Personalised recommendations